This report focuses on the global NK Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the NK Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Market segment by Type, the product can be split into
NK Cell Therapies
NK Cell Directed Antibodies
NK Cell agents took the largest market share segment, accounting for 82% and growing fastest
Market segment by Application, split into
Cancer
Gastrointestinal Diseases
Others
Cancer was the most widely used area at 66%
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global NK Cell Therapy status, future forecast, growth opportunity, key market and key players.
To present the NK Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of NK Cell Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The key players covered in this study
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Market segment by Type, the product can be split into
NK Cell Therapies
NK Cell Directed Antibodies
NK Cell agents took the largest market share segment, accounting for 82% and growing fastest
Market segment by Application, split into
Cancer
Gastrointestinal Diseases
Others
Cancer was the most widely used area at 66%
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global NK Cell Therapy status, future forecast, growth opportunity, key market and key players.
To present the NK Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of NK Cell Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 NK Cell Therapies
1.4.3 NK Cell Directed Antibodies
1.5 Market by Application
1.5.1 Global NK Cell Therapy Market Share by Application (2019-2025)
1.5.2 Cancer
1.5.3 Gastrointestinal Diseases
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 NK Cell Therapy Market Size
2.2 NK Cell Therapy Growth Trends by Regions
2.2.1 NK Cell Therapy Market Size by Regions (2019-2025)
2.2.2 NK Cell Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 NK Cell Therapy Market Size by by Players
3.1.1 Global NK Cell Therapy Revenue by by Players (2014-2019)
3.1.2 Global NK Cell Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2 NK Cell Therapy Key Players Head office and Area Served
3.3 Key Players NK Cell Therapy Product/Solution/Service
3.4 Date of Enter into NK Cell Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global NK Cell Therapy Market Size by Type (2014-2019)
4.2 Global NK Cell Therapy Market Size by Application (2014-2019)
5 North America
5.1 North America NK Cell Therapy Market Size (2014-2019)
5.2 NK Cell Therapy Key Players in North America
5.3 North America NK Cell Therapy Market Size by Type
5.4 North America NK Cell Therapy Market Size by Application
6 Europe
6.1 Europe NK Cell Therapy Market Size (2014-2019)
6.2 NK Cell Therapy Key Players in Europe
6.3 Europe NK Cell Therapy Market Size by Type
6.4 Europe NK Cell Therapy Market Size by Application
7 China
7.1 China NK Cell Therapy Market Size (2014-2019)
7.2 NK Cell Therapy Key Players in China
7.3 China NK Cell Therapy Market Size by Type
7.4 China NK Cell Therapy Market Size by Application
8 Japan
8.1 Japan NK Cell Therapy Market Size (2014-2019)
8.2 NK Cell Therapy Key Players in Japan
8.3 Japan NK Cell Therapy Market Size by Type
8.4 Japan NK Cell Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia NK Cell Therapy Market Size (2014-2019)
9.2 NK Cell Therapy Key Players in Southeast Asia
9.3 Southeast Asia NK Cell Therapy Market Size by Type
9.4 Southeast Asia NK Cell Therapy Market Size by Application
10 India
10.1 India NK Cell Therapy Market Size (2014-2019)
10.2 NK Cell Therapy Key Players in India
10.3 India NK Cell Therapy Market Size by Type
10.4 India NK Cell Therapy Market Size by Application
11 Central & South America
11.1 Central & South America NK Cell Therapy Market Size (2014-2019)
11.2 NK Cell Therapy Key Players in Central & South America
11.3 Central & South America NK Cell Therapy Market Size by Type
11.4 Central & South America NK Cell Therapy Market Size by Application
12 International Players Profiles
12.1 Nektar Therapeutics
12.1.1 Nektar Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 NK Cell Therapy Introduction
12.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2014-2019))
12.1.5 Nektar Therapeutics Recent Development
12.2 Innate Pharma SA
12.2.1 Innate Pharma SA Company Details
12.2.2 Company Description and Business Overview
12.2.3 NK Cell Therapy Introduction
12.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2014-2019)
12.2.5 Innate Pharma SA Recent Development
12.3 Affimed
12.3.1 Affimed Company Details
12.3.2 Company Description and Business Overview
12.3.3 NK Cell Therapy Introduction
12.3.4 Affimed Revenue in NK Cell Therapy Business (2014-2019)
12.3.5 Affimed Recent Development
12.4 Chipscreen Biosciences
12.4.1 Chipscreen Biosciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 NK Cell Therapy Introduction
12.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2014-2019)
12.4.5 Chipscreen Biosciences Recent Development
12.5 Fate Therapeutics
12.5.1 Fate Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 NK Cell Therapy Introduction
12.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
12.5.5 Fate Therapeutics Recent Development
12.6 Glycostem Therapeutics
12.6.1 Glycostem Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 NK Cell Therapy Introduction
12.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
12.6.5 Glycostem Therapeutics Recent Development
12.7 Dragonfly Therapeutics
12.7.1 Dragonfly Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 NK Cell Therapy Introduction
12.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
12.7.5 Dragonfly Therapeutics Recent Development
12.8 Kiadis Pharma
12.8.1 Kiadis Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 NK Cell Therapy Introduction
12.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2014-2019)
12.8.5 Kiadis Pharma Recent Development
12.9 NantWorks
12.9.1 NantWorks Company Details
12.9.2 Company Description and Business Overview
12.9.3 NK Cell Therapy Introduction
12.9.4 NantWorks Revenue in NK Cell Therapy Business (2014-2019)
12.9.5 NantWorks Recent Development
12.10 Nkarta Therapeutics
12.10.1 Nkarta Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 NK Cell Therapy Introduction
12.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
12.10.5 Nkarta Therapeutics Recent Development
12.11 Fortress Biotech
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 NK Cell Therapies
1.4.3 NK Cell Directed Antibodies
1.5 Market by Application
1.5.1 Global NK Cell Therapy Market Share by Application (2019-2025)
1.5.2 Cancer
1.5.3 Gastrointestinal Diseases
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 NK Cell Therapy Market Size
2.2 NK Cell Therapy Growth Trends by Regions
2.2.1 NK Cell Therapy Market Size by Regions (2019-2025)
2.2.2 NK Cell Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 NK Cell Therapy Market Size by by Players
3.1.1 Global NK Cell Therapy Revenue by by Players (2014-2019)
3.1.2 Global NK Cell Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2 NK Cell Therapy Key Players Head office and Area Served
3.3 Key Players NK Cell Therapy Product/Solution/Service
3.4 Date of Enter into NK Cell Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global NK Cell Therapy Market Size by Type (2014-2019)
4.2 Global NK Cell Therapy Market Size by Application (2014-2019)
5 North America
5.1 North America NK Cell Therapy Market Size (2014-2019)
5.2 NK Cell Therapy Key Players in North America
5.3 North America NK Cell Therapy Market Size by Type
5.4 North America NK Cell Therapy Market Size by Application
6 Europe
6.1 Europe NK Cell Therapy Market Size (2014-2019)
6.2 NK Cell Therapy Key Players in Europe
6.3 Europe NK Cell Therapy Market Size by Type
6.4 Europe NK Cell Therapy Market Size by Application
7 China
7.1 China NK Cell Therapy Market Size (2014-2019)
7.2 NK Cell Therapy Key Players in China
7.3 China NK Cell Therapy Market Size by Type
7.4 China NK Cell Therapy Market Size by Application
8 Japan
8.1 Japan NK Cell Therapy Market Size (2014-2019)
8.2 NK Cell Therapy Key Players in Japan
8.3 Japan NK Cell Therapy Market Size by Type
8.4 Japan NK Cell Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia NK Cell Therapy Market Size (2014-2019)
9.2 NK Cell Therapy Key Players in Southeast Asia
9.3 Southeast Asia NK Cell Therapy Market Size by Type
9.4 Southeast Asia NK Cell Therapy Market Size by Application
10 India
10.1 India NK Cell Therapy Market Size (2014-2019)
10.2 NK Cell Therapy Key Players in India
10.3 India NK Cell Therapy Market Size by Type
10.4 India NK Cell Therapy Market Size by Application
11 Central & South America
11.1 Central & South America NK Cell Therapy Market Size (2014-2019)
11.2 NK Cell Therapy Key Players in Central & South America
11.3 Central & South America NK Cell Therapy Market Size by Type
11.4 Central & South America NK Cell Therapy Market Size by Application
12 International Players Profiles
12.1 Nektar Therapeutics
12.1.1 Nektar Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 NK Cell Therapy Introduction
12.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2014-2019))
12.1.5 Nektar Therapeutics Recent Development
12.2 Innate Pharma SA
12.2.1 Innate Pharma SA Company Details
12.2.2 Company Description and Business Overview
12.2.3 NK Cell Therapy Introduction
12.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2014-2019)
12.2.5 Innate Pharma SA Recent Development
12.3 Affimed
12.3.1 Affimed Company Details
12.3.2 Company Description and Business Overview
12.3.3 NK Cell Therapy Introduction
12.3.4 Affimed Revenue in NK Cell Therapy Business (2014-2019)
12.3.5 Affimed Recent Development
12.4 Chipscreen Biosciences
12.4.1 Chipscreen Biosciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 NK Cell Therapy Introduction
12.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2014-2019)
12.4.5 Chipscreen Biosciences Recent Development
12.5 Fate Therapeutics
12.5.1 Fate Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 NK Cell Therapy Introduction
12.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
12.5.5 Fate Therapeutics Recent Development
12.6 Glycostem Therapeutics
12.6.1 Glycostem Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 NK Cell Therapy Introduction
12.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
12.6.5 Glycostem Therapeutics Recent Development
12.7 Dragonfly Therapeutics
12.7.1 Dragonfly Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 NK Cell Therapy Introduction
12.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
12.7.5 Dragonfly Therapeutics Recent Development
12.8 Kiadis Pharma
12.8.1 Kiadis Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 NK Cell Therapy Introduction
12.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2014-2019)
12.8.5 Kiadis Pharma Recent Development
12.9 NantWorks
12.9.1 NantWorks Company Details
12.9.2 Company Description and Business Overview
12.9.3 NK Cell Therapy Introduction
12.9.4 NantWorks Revenue in NK Cell Therapy Business (2014-2019)
12.9.5 NantWorks Recent Development
12.10 Nkarta Therapeutics
12.10.1 Nkarta Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 NK Cell Therapy Introduction
12.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
12.10.5 Nkarta Therapeutics Recent Development
12.11 Fortress Biotech
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
